E-LIB Suche - Ergebnisse für: Yoshino, Takayuki

1

SEAMARK: phase II study of first-line encorafenib and cetux..:

Elez, Elena ; Kopetz, Scott ; Tabernero, Josep...
Future Oncology. 20 (2024) 11 - p. 653-663 , 2024

Link: https://doi.org/10.2217/..

2

Standardizing data collection in adjuvant colon cancer tria..:

Taieb, Julien ; Basile, Debora ; Seligmann, Jenny...
European Journal of Cancer. , 2024

Link: https://doi.org/10.1016/..

3

Efficacy of immune checkpoint inhibitors for metastatic col..:

Cohen, Romain ; Raeisi, Morteza ; Chibaudel, Benoist...
European Journal of Cancer. 199 (2024) - p. 113537 , 2024

Link: https://doi.org/10.1016/..

4

Appropriate Relevancy and Reliability of Real-World Data fo..:

Bando, Hideaki ; Misumi, Toshihiro ; Sakamoto, Yasutoshi...
Clinical Colorectal Cancer. , 2024

Link: https://doi.org/10.1016/..

5

Bridging horizons beyond CIRCULATE-Japan: a new paradigm in..:

Hashimoto, Tadayoshi ; Nakamura, Yoshiaki ; Oki, Eiji...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 495-511 , 2024

Link: https://doi.org/10.1007/..

6

A Randomized Phase III Study of Arfolitixorin versus Leucov..:

Tabernero, Josep ; Yoshino, Takayuki ; Stintzing, Sebastian...
Cancer Research Communications. 4 (2024) 1 - p. 28-37 , 2024

Link: https://doi.org/10.1158/..

7

Cetuximab Every 2 Weeks Versus Standard Weekly Dosing Admin..:

Bokemeyer, Carsten ; Ciardiello, Fortunato ; Dubreuil, Olivier...
Future Oncology. 20 (2024) 7 - p. 393-407 , 2024

Link: https://doi.org/10.2217/..

8

A meta-analysis of efficacy and safety data from head-to-he..:

Yoshino, Takayuki ; Hooda, Naushin ; Younan, Diana...
European Journal of Cancer. 202 (2024) - p. 113975 , 2024

Link: https://doi.org/10.1016/..

9

Prognosis of patients with residual pathological disease af..:

Okunaka, Mashiro ; Kotani, Daisuke ; Fujiwara, Hisashi...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

10

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuxi..:

Kotani, Daisuke ; Takashima, Atsuo ; Kato, Takeshi...
Clinical Colorectal Cancer. , 2024

Link: https://doi.org/10.1016/..

11

Multiomic molecular characterization of the response to com..:

Takei, Shogo ; Tanaka, Yosuke ; Lin, Yi-Tzu...
Journal for ImmunoTherapy of Cancer. 12 (2024) 2 - p. e008210 , 2024

Link: https://doi.org/10.1136/..

12

Potential Efficacy of Shiunko for Anti-Epidermal Growth Fac..:

Okunaka, Mashiro ; Kotani, Daisuke ; Mishima, Saori...
Integrative Cancer Therapies. 23 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

13

Differential effects of theasinensins and epigallocatechin-..:

Narai-Kanayama, Asako ; Hayakawa, Sumio ; Yoshino, Takayuki...
Biochimica et Biophysica Acta (BBA) - Biomembranes. 1866 (2024) 5 - p. 184312 , 2024

Link: https://doi.org/10.1016/..

14

Phase II trial of niraparib forBRCA-mutated biliary tract, ..:

Kawamoto, Yasuyuki ; Morizane, Chigusa ; Komatsu, Yoshito...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

15

Plasma Angiogenic Factors as Predictors of the Efficacy of ..:

Yuki, Satoshi ; Yamazaki, Kentaro ; Sunakawa, Yu...
Clinical Colorectal Cancer. , 2024

Link: https://doi.org/10.1016/..